For pharmaceutical and medical device manufacturers of all sizes, it is important to stay on top of the latest regulations. Is your organization prepared for the upcoming expansion to CMS Open Payments reporting and changes to global reporting jurisdictions requirements?
MediSpend’s Legislative Watch puts the information you need at your fingertips. Let our experts help keep you informed of important changes.
To learn more, please provide us your information to access the MediSpend webinar “Legislative Watch Update”. In this webinar, our experts provide viewers with updates on transparency reporting in the United States and other international news for the life sciences industry. Highlights include:
- US legislation, including:
- Expansion of CMS Open Payments
- Updates to state laws, including California, Massachusetts and Colorado
- Updates to AdvaMed and PhRMA Codes
- Updates to Standards for Integrity and Independence in Accredited Continuing Education
- Global developments, including:
- New EFPIA Code
- Updates to the MedTech Europe Code
- Developments regarding the Italian “Sunshine Act”
- Updates to global transparency/HCP engagement rules, including the Philippines, Australia, Saudi Arabia and New Zealand
About MediSpend
MediSpend is a global technology company providing best-in-class solutions that enable life science companies to compliantly manage high-risk business functions through top-rated software and client services. MediSpend is the compliance system of record for some of the world’s largest pharmaceutical, medical device, dental and emerging biotech companies around the world. The MediSpend Global Compliance Suite represents the industry’s first global SaaS solution purpose-built to manage the end-to-end process of HCP engagement through transparency reporting, which includes software that facilitates external grant requests. MediSpend is headquartered in Portsmouth, N.H., with offices in Minnesota, New York, Pennsylvania and the Netherlands.